Presented by:
Meghan Harris, MSN APRN-NP CPNP-AC
Yael Derman, MSN APRN CPNP-AC CPHON®
Session Details: Day 2: May 14, Session 9 2:20 PM-3:20 PM EDT (1:20 pm CST / 12:20 pm MST / 11:20 am PST)
Overview of Session: This session will explore how osteosarcoma and Ewing’s sarcoma are the two most common primary malignant bone tumors in children and young adults, yet they exhibit distinct clinical, radiographic, histologic, and genetic characteristics. This lecture will provide a comparative analysis of these tumors, beginning with their typical age of onset, staging at presentation, and key diagnostic features. We will explore imaging modalities and histo-pathologic findings that aid in differentiation, along with a review of their genetic profiles, including implications for hereditary cancer syndromes such as Li-Fraumeni. Treatment strategies will be discussed, covering multimodal approaches such as chemotherapy, surgical resection, and radiation therapy. Lastly, we will examine patient outcomes, highlighting morbidity, mortality, and advancements in therapeutic protocols.
Learning Outcomes:
- Learners will be able to self-report increased ability to differentiate osteosarcoma vs. Ewing sarcoma according to age, stage, histologic, genetic, and radiographic features as well as treatment regimens.
- Learners will self-report an increase in confidence when caring for a patient with osteosarcoma and Ewing sarcoma
This contains 2 sections:
- Post-Session Evaluation
Continuing Education Credit
APHON will provide 1 nursing continuing professional development (NCPD) contact hour(s) for the successful completion of this session. Successful completion requires attendance for the entire session and the completion of the post-session evaluation.
The Spring Education Exchange (SEE) sessions and post-session evaluations will be available for 30 days.
The Association for Pediatric Hematology Oncology Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This provider is also approved by the California Board of Registered Nursing, Provider Number 14513.
None of the planners for this activity have relevant financial relationship(s) to disclose with ineligible companies.
Questions or concerns? Contact education@aphon.org.
The APHON Spring Education Exchange is sponsored by ONCC.